Results 91 to 100 of about 318,673 (186)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR [PDF]

open access: yes, 2019
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who ...
Berenguer, Juan   +14 more
core   +4 more sources

Association of CD4 cell count and antiretroviral therapy antibody production in Human Immunodeficiency virus seropositive subjects on antiretroviral drugs in Benin City, Nigeria.

open access: yesSokoto Journal of Medical Laboratory Science, 2022
Antiretroviral therapy (ART) is widely used and subjects on ART were reported to develop antibodies against these drugs when used as monotherapy. The aim of this study was to determine the proportion of HIV-sero positive subjects on antiretroviral ...
Progress Arhenrhen OBAZELU* 1 and Mathias Abiodun EMOKPAE 1
doaj  

Antibody-mediated prevention and treatment of HIV-1 infection

open access: yesRetrovirology, 2018
Novel broadly neutralizing antibodies targeting HIV-1 hold promise for their use in the prevention and treatment of HIV-1 infection. Pre-clinical results have encouraged the evaluation of these antibodies in healthy and HIV-1-infected humans.
Henning Gruell, Florian Klein
doaj   +1 more source

The Symmetrical Immune Network Theory and a New HIV Vaccine Concept [PDF]

open access: yes, 2010
The symmetrical immune network theory is based on Jerne’s network hypothesis. An improved version of the theory is presented. The theory is characterized by symmetrical stimulatory, inhibitory and killing interactions between idiotypic and ...
Geoffrey W. Hoffmann
core   +1 more source

Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques

open access: yesNature Communications
The details of the pediatric immune system that supports induction of antibodies capable of neutralizing geographically-diverse or heterologous HIV-1 is currently unclear.
Sommer Holmes   +34 more
doaj   +1 more source

Is an HIV vaccine possible?

open access: yesBrazilian Journal of Infectious Diseases
The road to the discovery of a vaccine for HIV has been arduous and will continue to be difficult over the ensuing twenty years. Most vaccines are developed by inducing neutralizing antibodies against the target pathogen or by using attenuated strains of
Nancy A. Wilson, David I. Watkins
doaj   +1 more source

Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies. [PDF]

open access: yesPLoS Pathog, 2023
Joyce C   +29 more
europepmc   +1 more source

Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India

open access: yesFrontiers in Immunology, 2018
Background: Infection with HIV-2, a retrovirus that is closely related to HIV-1, is characterized by slower disease progression and transmission, longer latency period and low or undetectable viremia.
K. K. Vidyavijayan   +9 more
doaj   +1 more source

Validation study of an automated chemiluminiscence assay to detect HIV antibodies in oral fluid specimens. [PDF]

open access: yesEur J Clin Microbiol Infect Dis, 2022
González V   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy